2012
DOI: 10.1158/0008-5472.can-11-3671
|View full text |Cite
|
Sign up to set email alerts
|

miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells

Abstract: Toxicity and relapses from the immunochemotherapy used to treat chronic lymphocytic leukemia (CLL) prompt continued interest in gentle but effective targeted treatment options for the mainly elderly population suffering from this disease. Here, we report the definition of critical CLL cell survival pathways that can be targeted by ectopic reexpression of the miRNA genes miR-130a and miR-143 which are widely downregulated in CLL. Notably, miR-130a inhibited autophagy by reducing autophagosome formation, an effe… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
143
0
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 184 publications
(155 citation statements)
references
References 44 publications
10
143
0
2
Order By: Relevance
“…Decreased expression of Dicer-1 by miR-130a causes downregulation of several miRNAs in the cell, which could explain the complexity of cell changes when manipulating internal levels of miR-130a in cells. 38 In summary, our study reveals miR-130a as an important regulator of C/EBP-e protein expression and thereby also as a regulator of normal granulopoiesis. …”
mentioning
confidence: 65%
“…Decreased expression of Dicer-1 by miR-130a causes downregulation of several miRNAs in the cell, which could explain the complexity of cell changes when manipulating internal levels of miR-130a in cells. 38 In summary, our study reveals miR-130a as an important regulator of C/EBP-e protein expression and thereby also as a regulator of normal granulopoiesis. …”
mentioning
confidence: 65%
“…Of the 8 miR-130/301 family members listed in TargetScan, we chose 4 members to study (miR-130a/b and miR-301a/b), based on their conserved expression in rodent and human pulmonary vascular cell types. Members of this miRNA family have been studied to a modest degree, mainly as isolated factors in cancer progression (13,14) and non-PH-related diseases (15)(16)(17)(18). Notably, these miRNAs share the same seed sequence (nucleotides 2-8) and consequently putative targets ( Figure 1B), but they are encoded at separate chromosomal loci, indicating that distinct transcriptional events modulate their expression.…”
Section: Introductionmentioning
confidence: 99%
“…To date, an increasing number of miRNAs are being discovered as key regulators of many different cellular processes, in particular those related to autophagy death in cells of different tumor, like melanoma, 37 hepatocellular carcinoma, 38 myelogenous leukemia, 39 colon, 40 cervical, 41 and breast cancer; 42 however, to date, only few reports identified miRNA sequences (i.e., miR-30a, miR-21, and miR10b) directly involved in the regulation of the autophagic process in glioma cells. [43][44][45] Among oncogenic miRNAs, one of the best-characterized is miR-17-92, a polycistronic miRNA cluster, designated as OncomiR-1.…”
Section: Discussionmentioning
confidence: 99%